And So It Grows... European Pharmaceutical-Biotech Industry Investing Billions in Capital Construction Projects, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwired) -- 03/23/16 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the North American , which includes coverage of pharmaceuticals, biologicals, medical devices and cosmetics, continues to return a healthy capital expenditures (capex) investment profile, Europe's volume of project activity cannot be ignored. Barely months into the launch of the expansion of project coverage into Europe, over $14.5 billion in active capital and maintenance (MRO) activity across the pond has been identified and reported upon.
Within this article: Description of Pharma-Biotech Development in Europe.
For details, , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
Brian Ford
(713) 980-9393
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 23.03.2016 - 11:30 Uhr
Sprache: Deutsch
News-ID 459374
Anzahl Zeichen: 0
contact information:
Town:
SUGAR LAND, TX
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 354 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"And So It Grows... European Pharmaceutical-Biotech Industry Investing Billions in Capital Construction Projects, an Industrial Info News Alert"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
